The Dutch Molecular Pathology Center (DMPC) at Utrecht University’s faculty of Veterinary Medicine and the company InnoSer will in June 2013 begin to bundle their expertise and services. InnoSer will make use of the specific expertise of the DMPC for its clients in order to analyse transgene models. The uniting of the services means that clients are optimally facilitated in finding and analysing models and therapies for humane diseases.
Alain de Bruin, director of the DMPC: “This collaboration ensures that the specific expertise from making up until and including the analysis of transgene models becomes centralised. Thereby we offer high quality for our academic partners and customers. Next to that it offers the possibility to increase our fundamental knowledge about genes.”
“The collaboration with DMPC is a wonderful addition to our service package. It is our objective to serve our academic partners and customers, in research into transgene models, with a complete and high value service package with very attractive costs. InnoSer is delighted with the upcoming unique collaboration with the DMPC. This is an excellent example of the advantages of a public-private collaboration” says Jan Bartels, director InnoSer.
Start project: November 2012
Goal: Strategic collaboration between DMPC (Faculty Veterinary Medicine) and InnoSer
Role UtrechtVC/Utrecht Holdings: formulation of budget / contract negotiations
UtrechtVC contact: Thomas König